Information  X 
Enter a valid email address

Oxeco PLC (OXE)

  Print      Mail a friend

Wednesday 18 March, 2009

Oxeco PLC

Strategic Review and Director

RNS Number : 0585P
Oxeco PLC
18 March 2009

18 March 2009

Oxeco Plc ('Oxeco 'or 'the Company')

Strategic Review and Directorate Change

Investment Strategy

At the time of the Company's admission to AIM in December 2006 the Board advised shareholders of their focus on the technology and science sectors. Since the acquisition of Oxray Limited ('Oxray') in June 2007, the Board have focused on seeking complementary acquisitions to Oxray in the molecular structure determination business.

The Board has reviewed a number of investment opportunities that are in areas complementary to the Oxray business although none were considered to offer sufficiently attractive prospects for shareholders. It now intends to revert to seeking opportunities within the general technology and science sectors. 

The Board is reviewing its options in relation to the existing Oxray business and will keep shareholders appraised of the ongoing strategic review. 

Directorate Change

Jussi Westergren, who joined the Company at the time of the Oxray acquisition, has today resigned as Chairman of Oxeco and the Company's Finance Director, Michael Bretherton, has been appointed to the role as replacement Chairman. 


Michael Bretherton

Oxeco plc


+44 (0) 207099 7266

 Ray Zimmerman/Jonathan Evans   

Zimmerman Adams International Limited

+44 (0) 207 060 1760


This information is provided by RNS
The company news service from the London Stock Exchange

a d v e r t i s e m e n t